Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Adjuvant to Magnesium Sulphate for ICP in Pre-eclampsia
NCT05119101Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Optic nerve sheath diameter changes. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05119101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119101.